Peri-implant infections by de Waal, Yvonne Catharina Maria
  
 University of Groningen
Peri-implant infections
de Waal, Yvonne Catharina Maria
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2015
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
de Waal, Y. C. M. (2015). Peri-implant infections. [Groningen]: University of Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




























During the past decades, dental implant therapy has developed into a successful 
treatment option, both for partial and complete edentulism. The concept of osseoin-
tegration was developed in the 1960s by P.I. Brånemark (1929-2014) and co-workers 
at the University of Göteborg. They were also the first to describe the use of os-
seointegrated dental implants for anchorage of dental prostheses (Brånemark et al. 
1969). In the years thereafter, many different implant systems have been developed 
and the indications for their application have been gradually extended. Nowadays, 
the implant retained overdenture has even become the first choice of treatment for 
the edentulous mandible (Feine et al. 2002). In 2007 it was calculated by Statistics 
Netherlands that 8% of the Dutch population of fully edentulous patients have dental 
implants to support a full prosthesis. Overall, there were 800 thousand adults in the 
Netherlands (6.6% of the total adult population) with one or more dental implants and 
it is expected that this number will continuously increase.
High survival rates of dental implants are generally reported (5-years survival rate 
95.7%-97.1%; 10-years survival rate 89.8%-92.8%) (Pjetursson et al. 2012, Jung et al. 
2012, Pjetursson et al. 2014). Yet, these survival rates do not surpass the longevity of 
natural teeth (Holm-Pedersen et al. 2007). Teeth surrounded by healthy periodon-
tal tissues yield longevity of up to 99.5% over 50 years. Periodontally compromised 
teeth, that are treated and maintained regularly, or endodontically treated non-vital 
teeth still yield high survival and success rates: 10-year survival rate of 92-93% for peri-
odontally compromised teeth, 10-year survival rate of > 90% for primary endodonti-
cally treated teeth as well as retreated teeth, 5-year survival rate < 80% for teeth 
with existing periapical pathology (Holm-Pedersen et al. 2007). It has therefore been 
stated that teeth should be given priority over dental implants whenever possible, un-
less multiple risks jeopardize their long-term prognosis (Lang et al. 2007). 
Implant failure and success
In evaluating implant treatment, survival rate is often used as primary outcome. How-
ever, reporting on the clinical condition of surviving implants, i.e. implant success, is 
also important. To be considered successful, an implant-supported restoration has to 
meet certain criteria in terms of function (ability to chew), tissue physiology (absence 
of pain and other pathological processes) and user satisfaction (esthetics and absence 
of discomfort) (Esposito et al. 1998b). If the performance of an implant-supported 
restoration, measured in some quantitative way, falls below an acceptable level it is 
regarded a failure.
Failures can be due to technical and biological complications. Technical complications 
are caused by mechanical damage of the implant, implant components or suprastruc-
tures. Biological complications refer to disturbances in the function of the implant 
characterized by biological processes affecting the tissues supporting the implant 
(Berglundh et al. 2002).  According to occurrence in time biological complications can 
further be divided into early failures and late failures. In early failures osseointegration 
has not been sufficiently established and it represents an interference with the healing 
process. Late failures are characterized by a failure to maintain osseointegration and 
are caused by a process of loss of osseointegration (Esposito et al. 1998b). The main 
etiological factors for early dental implant failure are surgical trauma, impaired healing 
ability, infection and insufficient bone volume and quality (Esposito et al. 1998a). In 
late dental implant failures peri-implant infections are considered to play the predomi-
nant role (Esposito et al. 1998a).
Epidemiology of peri-implant infections
Peri-implant infection results from a disturbance of the balance between the micro-
biological challenge and host response. Infection limited to the peri-implant mucosa 
is called peri-implant mucositis. Peri-implantitis is characterized by the additional loss 
of supporting bone (Zitzmann & Berglundh 2008). If peri-implant infection is left un-
treated it may ultimately lead to implant loss. 
The 10-years prevalence of peri-implant mucositis is estimated to be 63% on patient 
level (range 39.4-76.6, 95%CI 58.9-67.1) and 30% on implant level (range 8.9-48.1, 
95%CI 28.6-32.8) (Atieh et al. 2013). The 10-years prevalence of peri-implantitis rang-
es from 6% to 47% on patient level (mean 18.8%, 95%CI 16.8-20.8) and from 2% to 
37% on implant level (mean 9.6%, 95%CI 8.8-10.4) (Atieh et al. 2013). Based on these 
prevalence figures it can be concluded that peri-implant infection following dental 
implant placement is a frequently occurring complication. 
This is in line with observations on other ‘permanent’ permucosal/percutaneous os-
seointegrated medical implants, for example implants for limb prosthesis fixation 
(Campoccia et al. 2013). Infection rates for this relatively new type of percutaneous 
devices range from 18% to 55% up to 5 years (Tillander et al. 2010, Tsikandylakis et 
al. 2014, Brånemark et al. 2014). Infection rates for totally internal osseointegrated 
implant devices, such as knee or hip prostheses are much lower, being approximately 
2% within 2 years of functioning and about 0.5% between 2 and 10 years (Ong et al. 
2009, Kurtz et al. 2010).  The reason for this lower infection rate is that totally inter-
nal implants are placed in a sterile environment and are protected from exposure to 
external contaminations. Infections of these types of implants are usually caused by 
contamination of the implant surface before or during surgery or haematogenous 
seeding from a distant infected site (Campoccia et al. 2013). Permucosal/percutane-
ous implants on the other hand penetrate the protective body barriers, i.e. mucosal 
membranes and skin, and create conditions even for limited-aggressive opportunistic 
pathogens to gain access to and invade internal tissues (Campoccia et al. 2013).
Pathophysiology and etiology of peri-implant infections
Plaque accumulation at dental implant-supported restorations induces an inflamma-
tory response in the peri-implant mucosa (peri-implant mucositis), which is character-
ized by increased proportions of T- and B-cells in the infiltrated connective tissue area 
(Zitzmann et al. 2001). This host response to the bacterial challenge is similar to the 
development of gingivitis at teeth (Pontoriero et al. 1994, Zitzmann et al. 2001). Be-
cause it is expected that peri-implant mucositis proceeds peri-implantitis as gingivitis 
proceeds periodontitis, treatment of peri-implant mucositis has to be the pre-requisite 
for the prevention of peri-implantitis (Lang et al. 2011b). Failure to do so may result 
in gradual enlargement of the inflammatory cell infiltrate and increase in numbers of 
plasma cells, lymphocytes, neutrophil granulocytes and macrophages (Berglundh et 
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often more pronounced than in periodontitis and is in most cases located apical of the 
pocket epithelium and close to the alveolar bone (Berglundh et al. 2011).  
Microbiology of peri-implant infections
The microbiota associated with peri-implant infection varies from person to person 
and is in most cases dominated by a variety of Gram-negative anaerobic bacteria 
(Mombelli & Décaillet 2011, Kumar et al. 2012). The use of new molecular techniques 
such as polymerase chain reaction and pyrosequencing has revealed that the peri-
odontal and peri-implant microflora is far more diverse than previously thought and 
harbors ‘uncultivable’ species of which the potential pathogenic role in periodontal 
and peri-implant diseases is unknown (Kumar et al. 2003, Kumar et al. 2012). Never-
theless, several periodontal bacteria have been associated with peri-implant disease, 
such as Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tanner-
ella forsythia, Fusobacterium nucleatum and Prevotella intermedia (Mombelli et al. 
1987, Leonhardt et al. 1999, Shibli et al. 2008, Kumar et al. 2012). However, there are 
also some marked differences between the periodontal and peri-implant microbiota. 
The diversity of peri-implant biofilms, in both health and disease, seems significantly 
lower than the diversity of subgingival biofilms (Kumar et al. 2012). Furthermore, sev-
eral species, including previously unsuspected and unknown organisms, seem unique 
to the peri-implant niche, for example species belonging to the genera Anaerococ-
cus, Anaerovorax, Exiguobacterium and Burkholderia (Kumar et al. 2012). Despite the 
fact that it has convincingly been demonstrated that micro-organisms are involved in 
the peri-implant disease process there is no proof that they are always the primary 
cause of the condition (Mombelli & Décaillet 2011). A suitable ecological environment 
is necessary to facilitate bacterial colonization and maturation of biofilms. Changes in 
local ecological conditions that favor the outgrowth of bacterial pathogens may be 
viewed as the true origin of peri-implant disease (Mombelli & Décaillet 2011). 
Risk factors of peri-implant infections
Patients with a history of treated periodontitis have a significantly greater risk of devel-
oping peri-implantitis than patients without such a history (odds ratios 3.1-4.7) (Heitz-
Mayfield & Huynh-Ba 2009). This could be due to the fact that periodontitis patients 
generally harbor more putative periodontal pathogens in their oral cavity than non-
periodontitis patients (Van Winkelhoff et al. 2002, Kumar et al. 2003, Boutaga et al. 
2006) and/or these patients may have a  potentially higher genetic susceptibility to 
develop periodontal/peri-implant disease (Gruica et al. 2004, Laine et al. 2006). Smok-
ers have a significantly higher risk for developing peri-implantitis than non-smokers 
(odds ratios 3.6-4.6) and this association seems to be dose-related (Heitz-Mayfield 
2008, Heitz-Mayfield & Huynh-Ba 2009). Furthermore there seems to be a synergis-
tic effect between smoking and specific interleukin (IL-1) gene polymorphisms and a 
higher risk for peri-implantitis (Gruica et al. 2004, Laine et al. 2006). The third major 
risk factor for peri-implantitis is poor oral hygiene (Heitz-Mayfield 2008). Presence of 
plaque at > 30% of the sites is associated with increased risk for peri-implant mucositis 
and peri-implantitis (Ferreira et al. 2006). This association between full-mouth plaque 
score and peri-implant infection seems to be dose dependent. Ferreira et al. (2006) 
found an odds ratio for very poor oral hygiene and peri-implantitis of 14.3 (95%CI 
9.1-28.7). Lack of accessibility for oral hygiene at implant sites, for example due to 
improper prosthetic reconstructions, has been related to presence of peri-implantitis 
(Serino & Ström 2009). Furthermore, progression from peri-implant mucositis to peri-
implantitis is significantly associated with lack of preventive maintenance (Costa et al. 
2012). Attendance in a structured maintenance program seems to be strongly related 
to implant survival (Anner et al. 2010) and a lower prevalence of peri-implantitis (Atieh 
et al. 2013). Other factors that have been suggested as potential risk factors for de-
velopment of peri-implant infection include absence of keratinized mucosa (Brito et 
al. 2014), alcohol consumption (Galindo-Moreno et al. 2005), diabetes (Ferreira et 
al. 2006), rough implant surface (Astrand et al. 2004) and implant brand (Derks et al. 
2015). However, the evidence on these factors is limited and sometimes conflicting.  
Loose components, caused by fracture of the implant or abutment, or iatrogenic fac-
tors such as submucosal remnants of dental cement, implant malpositioning or ill-
fitting suprastructures might also initiate peri-implant inflammation, by provoking a 
foreign body reaction and/or by creating local ecological conditions which facilitate 
undisturbed biofilm-formation (Wilson 2009). 
The role of implant overload on peri-implant bone loss and peri-implant infections is 
controversial and, due to limited available evidence, not clear. However, it has been 
suggested that the effect depends on the health status of the peri-implant mucosa 
(Naert et al. 2012). Supra-occlusal contacts acting in a non-inflamed peri-implant en-
vironment do not seem to negatively affect osseointegration, whereas supra-occlusal 
contacts in the presence of inflammation seem to increase the plaque-induced bone 
resorption (Naert et al. 2012).
Titanium allergy and intolerance have also been suggested as possible initiating fac-
tors for peri-implant disease and causes for implant failure (Siddiqi et al. 2011). The 
prevalence of true titanium allergy seems to be low in dental implant patients (Sicilia et 
al. 2008), but debris-mediated titanium intolerance could play a more significant role 
in dental implant failure (Jacobi-Gresser et al. 2013). In fact, wear, or debris-mediated 
implant loosening, is the most common cause of failure in hip and knee arthroplas-
ties (Landgraeber et al. 2014). Corrosion products of titanium implants may initiate 
macrophages, through phagocytosis of titanium particles, to produce inflammatory 
cytokines, leading to osteolysis and loosening of the implant. It has been shown that 
host factors, or the immune response to titanium particles, plays a significant role 
in this process. Particularly patients with risk genotypes of IL1A, IL1B, IL1RN and/or 
TNFA may be more susceptible to this type of dental implant failure than others (Taira 
et al. 2009, Jacobi-Gresser et al. 2013). 
Diagnosis of peri-implant infections
Essential in the diagnosis of peri-implant disease is probing of the peri-implant sulcus. 
An increase in probing pocket depth over time is associated with attachment loss and 
bone loss (Lang et al. 1993, Schou et al. 1993a, Schou et al. 1993b). Probing with a 
light force does not seem to damage the peri-implant tissues and is recommended 
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that the mucosal attachment around implants after probing with a light force (0.25 N) 
is completely recovered within five days (Etter et al. 2002). Bleeding after gentle prob-
ing is a second valuable parameter for diagnosis of peri-implant infections (Heitz-May-
field 2008). Bleeding on probing shows a high negative predictive value, i.e. absence 
of bleeding on probing is indicative for healthy peri-implant conditions (Jepsen et al. 
1996, Luterbacher et al. 2000). Presence of bleeding on probing at more than half 
of the recall visits over a 2-year period is associated with progression of peri-implant 
disease (increase in probing pocket depth and/or bone loss) (Luterbacher et al. 2000). 
The presence of suppuration indicates presence of an inflammatory lesion and is most 
often related to a bacterial infection (Heitz-Mayfield 2008). Suppuration is associated 
with progressive bone loss (Roos-Jansåker et al. 2006, Fransson et al. 2008) and peri-
implantitis (Roos-Jansåker et al. 2006, Lang et al. 2011b) and is a frequent observa-
tion at implants with peri-implantitis (Lang et al. 2011a). Radiographs are required for 
evaluation of peri-implant bone levels and for distinguishing peri-implant mucositis 
from peri-implantitis (Heitz-Mayfield 2008). Progressive bone loss, as observed by 
comparing two consecutive radiographs, is indicative for presence of peri-implantitis.
In the differential diagnosis of peri-implant disease it is important to include identifi-
cation of possible underlying problems, even if suppuration or presence of a biofilm 
point to a bacterial infection (Mombelli & Décaillet 2011). In addition, peri-implant 
bone loss as a result of peri-implant infection should be distinguished from bone loss 
as a result of remodeling or overload. Physiological remodeling of peri-implant bone 
takes place during the first few months after implant placement when the biologi-
cal width is created (Berglundh & Lindhe 1996, Sculean et al. 2014). The amount of 
physiological bone loss differs between implant systems and depends, amongst other 
factors, on implant positioning (Tatarakis et al. 2012). Initial bone loss might be more 
pronounced at implants that are placed too deep (Hämmerle et al. 1996) or to close 
to other structures (Tarnow et al. 2000). Implants that are placed too deep generally 
also have deeper initial peri-implant pockets. This by its self might also be considered 
an initiating factor for peri-implant disease because pockets of 5 mm or more can be 
viewed as protected habitats for putative pathogens (Mombelli & Décaillet 2011). 
Treatment of peri-implant infections
Once peri-implant infection has been diagnosed it is essential to initiate a prompt 
curative intervention in order to resolve the inflammatory lesion and prevent (further) 
bone loss. Mechanical non-surgical therapy can be effective for the treatment of peri-
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